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 The 8 HAAs do not contribute signiﬁcantly to the bacterial in vitro mutagenicity of CS.
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A B S T R A C T
Heterocyclic aromatic amines (HAAs) rank among the strongest known mutagens. Approximately
30 HAAs have been found in cooked foods (broiled, fried, and grilled) and several HAAs have been
characterized as animal carcinogens. Nine HAAs have also been reported to be constituents of cigarette
smoke (CS) raising concerns that HAAs might contribute signiﬁcantly to the known carcinogenicity of CS.
As HAAs are found predominantly in the total particulate matter (TPM) of CS, an improved method for the
quantiﬁcation of HAAs in TPM is reported allowing detection and quantiﬁcation of 8 HAAs in a single run.
The mutagenic potency of these HAAs and that of TPM from the reference cigarette 2R4F was determined
in the Salmonella Reverse Mutation Assay (Ames assay) with tester strain TA98 and a metabolic
activation system. The 8 HAAs, when applied together in the Ames assay, showed a clear sub-additive
response. Likewise, the combination of HAAs and TPM, if at all, gave rise to a slight sub-additive response.
In both cases, however, the sub-additive response in the Ames assay was observed at HAA doses that are
far above the amounts found in CS. The contribution of the individual HAAs to the total mutagenic activity
of TPM was calculated and experimentally conﬁrmed to be approximately 1% of the total mutagenic
activity. Thus, HAAs do not contribute signiﬁcantly to the bacterial in vitro mutagenicity of CS TPM.
ã 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Since the detection of substances with very high bacterial
mutagenicity in cooked/broiled meat and ﬁsh and their identiﬁca-
tion as heterocyclic aromatic amines (HAAs), (Commoner et al.,
1978; Sugimura et al., 1977a,b) this class of compounds has
initiated extensive research that is still ongoing. HAAs are formed
typically at higher temperatures (140–165 C) as the result of
Maillard reactions involving creatinine, free amino acids (espe-
cially tryptophan and glutamic acid), and sugars (Wakabayashi
et al., 1993). Special attention is given in the literature to the
following carboline type of HAAs: MeAaC, AaC, Trp-P-1, Trp-P-2,
Glu-P-1, Glu-P-2, and the aminoimidazo type of HAAs: IQ, MelQ,
MelQx, PhlP. Harman and norharman, although b-carbolines, are
not considered as member of the HAA class in most publications asarticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
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HAAs can undergo metabolic activation by N-hydroxylation
producing an intermediate (arylnitrenium ion) which has been
implicated in general toxicity and DNA damage (Turesky and Le
Marchand, 2011).
With the exception of harman and norharman, the mentioned
HAAs exhibit a clear in vitro activity inducing reverse mutations in
Salmonella typhimurium (Ames assay), morphological transforma-
tion in mouse ﬁbroblasts, micronucleus induction in human cells,
and DNA strand breaks (Comet Assay) in human cells (Pfau et al.,
1999; Dumont et al., 2010; Jagerstad and Skog, 2005; Sorensen
et al., 1996; Viegas et al., 2012; Haza and Morales, 2011; Platt et al.,
2010), and genotoxic effects in vivo as DNA adducts (Arimoto-
Kobayashi et al., 2006; Dingley et al., 2003). Micronuclei formation
could be demonstrated for PhlP in mice but not for MelQ and IQ
(Durling and Abramsson-Zetterberg, 2005). The carcinogenicity of
PhlP, MelQ, and IQ in mice and rats in various organs, like liver,
pancreas, colon, mammary gland, and prostate is well established
at doses around 10 mg/kg/day (Ohgaki et al., 1986; Schut and
Snyderwine, 1999; Wakabayashi et al., 1993). Carcinogenicity
studies in nonhuman primates with PhlP, MelQ, and IQ could only
demonstrate a carcinogenic action of IQ in the liver at doses of
10 and 20 mg/kg/day (Takayama et al., 2008). Differences in
metabolism between rodents and primates account for the
observed differences in the carcinogenic effects (Turesky, 2005).
In humans, no occupational exposures to pure HAAs have been
reported. However, since the detection of HAAs in food, there are
concerns that their presence in food might cause tumors in men
(Commoner et al., 1978; Sugimura et al., 1977a,b). Several
epidemiological studies have tried to ﬁnd an association between
the intake of, e.g., cooked meat, cooked ﬁsh, or fried potatoes and
several tumor types, especially those of the colon (WCRF/AICR,
1997). These studies are mainly based on questionnaires exploring
the diet of the participants. For colorectal adenomas or carcinomas
there are more studies that showed an association (although not
always statistically signiﬁcant) than those that gave a negative
result (Kim et al., 2013; Berlau et al., 2004). Associations between
HAAs and tumors at other sites are in summary even more
inconclusive. Considering these uncertainties, insufﬁcient evi-
dence exists to establish a deﬁnite conclusion on the role of
HAAs in the genesis of human tumors (Alaejos et al., 2008;
Santarelli et al., 2008). This conclusion is consistent with the
assessments of the International Agency for Research on Cancer
that has not listed any of the HAAs as a deﬁnite human carcinogen
(IARC, 2015); IQ was classiﬁed as a ‘probable human carcinogen’
(Group 2A) and other assessed HAAs (AaC, Glu-P-1, Glu-P-2,
MeAaC, MelQ, MelQx, Trp-P-1, Trp-P-2) as ‘possible human
carcinogens’ (Group 2B). Comparing the doses that gave rise to
a distinct tumor development in rodents and monkeys with the
estimated daily oral intake of HAAs by humans shows that the
estimated human exposure is more than 1000 times lower. As
such, a not yet identiﬁed mechanism would be needed to explain a
link between HAAs and human tumorigenicity (Wakabayashi
et al., 1993).
Maillard reactions are well-known to occur in the burning
cigarette and as all components necessary to form HAAs are
present in tobacco, it has been suggested that HAAs should also be
found in cigarette smoke. Three years after the initial studies of
Sugimura et al. at the National Cancer Center Research Institute in
Japan where HAAs in the diet could be identiﬁed (Sugimura et al.,
1977a,b) the ﬁrst HAAs, AaC and MeAaC, were identiﬁed and
quantiﬁed in TPM of cigarette smoke (Yoshida and Matsumoto,
1980; Matsumoto et al., 1981). Further studies by several different
laboratories using different analytical methodologies identiﬁed
additional HAAs in TPM (Yamashita et al., 1986; Kanai et al., 1990;
Sasaki et al., 2001a; Manabe et al., 1991, 1990; Manabe and Wada,1990; Wakabayashi et al., 1995; Kataoka et al., 1998; Smith et al.,
2004; Turesky et al., 2005; Saha et al., 2009; Zhang et al., 2011).
Despite some concerns regarding the biological activity of HAAs
in TPM, it was only in 1997 that several HAAs were included in a
revised list of “[c]arcinogens in tobacco and cigarette smoke”
issued by Hoffmann and Hoffmann (1997). More recently, the U.S.
Food and Drug Administration (FDA) has included 8 HAAs in their
list of 93 ‘Harmful and Potentially Harmful Constituents (HPHCs) in
tobacco products and tobacco smoke’ (FDA, 2012). A more recent
list of 39 priority toxic contents and emissions of tobacco products
does not include HAAs (WHO, 2015).
As data on the mutagenicity of HAAs in the context of TPM are
scarce and, regarding interactions, nearly non-existent, the
research presented here was targeted to corroborate the existing
potency data on single HAAs, their occurrence in TPM, their
contribution to the overall mutagenicity of TPM, and their
interactions with TPM or between the HAAs themselves. Hereby,
an improved analytical method for the quantiﬁcation of the HAAs
in TPM was applied.
2. Materials and methods
2.1. Cigarettes, mainstream smoke (MS) generation and trapping
The American blended reference cigarettes 2R4F were obtained
from the University of Kentucky, Kentucky Tobacco Research and
Development Center (Davis and Vaught, 1990). The cigarettes were
conditioned unpacked in open containers according to Interna-
tional Organization for Standardization (ISO) standard 3402 (ISO,
1999), i.e., at least 48 h at target conditions of 22 C  1 C and a
relative humidity of 60%  3%. MS was generated on a 20-port
Borgwaldt smoking machine (RM20H, Hamburg, Germany)
according to ISO Standard 3308 (ISO, 1991). In brief, puff volume,
puff duration, and puff frequency were 35 ml, 2 s, and 1/min,
respectively.
The yields per cigarette (means  SE, N = 4) obtained under
these conditions were 9.77  0.04 mg TPM, 0.71 0.01 mg nicotine,
1.08  0.04 mg water, and 11.2  0.1 mg carbon monoxide.
The TPM of 5 cigarettes/sample was trapped on a glass ﬁber
ﬁlter (Cambridge ﬁlters; Filtrona Instruments, Milton Keynes, UK)
for chemical analyses and TPM from 20 cigarettes (on 2 ﬁlters) for
mutagenicity determination.
2.2. Sample preparation and chemical analyses
The analytical method used for the identiﬁcation and quantiﬁ-
cation of HAAs was based on a previously published method
(Sasaki et al., 2001b) with modiﬁcation as follows (major differ-
ences to Sasaki et al. were triple quadrupole technology in both PCI
and NCI modes instead of single quadrupole technology only in the
NCI mode):
TPM trapped on glass ﬁber ﬁlters was extracted with 11 ml
hydrochloric acid (0.1 N) containing 100 ml calibration standard
solution (d3-IQ; Toronto Research Chemicals, Inc. (Toronto,
Ontario, Canada)) for 30 min in an ultrasonic bath. The extract
was washed two times by shortly shaking with approximately
10 ml dichloromethane which was removed and discarded. Then
the pH was adjusted by the addition of 15 ml of K2CO3 solution
(saturated) and washed two times again with 10 ml dichloro-
methane, each. After each washing step, the dichloromethane
extracts were concentrated under a nitrogen ﬂow to 2 ml. The
sample was derivatized for 30 min at 70 C by addition of 20 ml
pyridine and 4 ml pentaﬂuoro acetic acid anhydride (PFAA) prior to
addition of 4 ml N,N-dimethylformamide acetal-methyl-8 (Sigma–
Aldrich, Buchs, Germany). The solution was concentrated to
dryness under nitrogen and the residue dissolved in 0.1 ml
Table 1
Yields of heterocyclic aromatic amines in TPM of the reference cigarette 2R4F.
HAA Yield Quantiﬁcation limit
(ng/cigarette)
(ng/cigarette) (ng/mg TPM)
Mean SD Mean SD
AaC 28.4 0.8 3.0 0.09 0.016
MeAaC 7.57 0.31 0.81 0.03 0.90
Trp-P-2 4.40 0.22 0.47 0.02 0.59
Glu-P-1 0.043 0.003 0.005 0.0003 0.030
Glu-P-2 0.211 0.008 0.023 0.001 0.05
PhlP 0.086 0.004 0.009 0.0004 0.015
IQ 0.324 0.016 0.035 0.002 0.081
MelQ 0.338 0.027 0.036 0.003 0.32
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tandem mass spectrometer (GC–MS/MS).
The GC–MS/MS system consisted of a 5890 GC (Agilent
Technologies, Waldbronn, Germany), equipped with an A200S
autosampler (CTC Analytics, Zwingen, Switzerland) and coupled to
a TSQ 700 triple quadrupole mass spectrometer (Finnigan MAT;
Thermo Fisher, MA, USA); the system was controlled by an ALPHA
station 255/233 (Digital Equipment). The chromatographic column
was a DB17-MS (30 m  0.25 mm, 0.25 pm ﬁlm thickness; J&W
Scientiﬁc—Agilent Technologies, Waldbronn, Germany). The carri-
er gas was helium at a head pressure of 200 kPa. The GC oven
temperature program was 1 min at 100 C, then ramped to 300 C
at 20 C/min. The sample injector was kept at 270 C and the
transfer line at 250 C. The sample injection was made in splitless
mode using a focus liner (SGE—Agilent Technologies, Waldbronn,
Germany). The ion source temperature was 200 C. The
amines were ionized in the PCI and NCI mode with isobutane as
CI gas (3500 mtorr). The tandem mass spectrometer was operated
in the Single Ion Monitoring (SIM) mode, monitoring the molecule
ions of the HAAs derivatives and their deuterated analogues. SIM
masses for quantitation were: AaC = 330.1, MeAaC = 358.1, Trp-P-
2 = 343.1, Glu-P-1 = 344.1, Glu-P-2 = 330.1, PhIP = 385.1, IQ = 359.1,
MeIQ = 373.1.
All HAA standards (reference and internal standards) were
purchased from Toronto Research Chemicals, Inc. (Toronto,
Ontario, Canada) and had a purity of 97%.
2.3. Determination of bacterial mutagenicity
Mutagenicity of TPM was assessed in the Salmonella Reverse
Mutation Assay (Maron and Ames, 1983) according to the
Organization for Economic Co-operation and Development (OECD)
guideline 471 (OECD, 1997) as previously described (Roemer et al.,
2012). Determinations were performed in the plate incorporation
assay version with the tester strain TA98, in the presence of a
metabolic activation system consisting of the post mitochondrial
fraction (S9) of liver cells, i.e., those assay conditions giving rise to
the most pronounced effects.
TPM was extracted from the glass ﬁber ﬁlters with DMSO and
the TPM extract/suspension was separated from the glass ﬁbers by
centrifugation. The TPM-DMSO suspensions were stored immedi-
ately after preparation at 75 1.5 C until use. For further details
on smoke generation see Section 2.1.
The bacteria were derived from stock cultures maintained at
196 C with 0.09 ml DMSO/ml cell suspension. They were
prepared from overnight cultures inoculated with the ﬁrst
cultivation of the master copies originally received (Bruce N.
Ames, Berkeley, CA). An aliquot (10 ml) of the thawed stock culture
was used as inoculum cultivated in 30 ml of nutrient broth at
36  1 C in a shaking incubator for approximately 11 h before
harvest. The bacteria were then in a late logarithmic/early
stationary growth phase.
For plating and exposure, bacteria suspended in culture
medium, TPM dissolved in DMSO or DMSO alone, S9 mix
(supernatant after centrifugation of liver homogenate from Aroclor
1254-induced rats with a NADPH-regenerating system in 0.1 mol/l
phosphate buffer, pH 7.4 (Cytotest Cell Research, Rossdorf,
Germany)), were added to the top agar supplemented with
histidine (His) and biotin (0.05 nmol each). The components were
mixed and spread evenly on minimal glucose agar plates. After the
top agar hardened, the plates were incubated in the dark at
36  1 C for 44 to 48 h. The number of His+ revertant colonies was
determined with an automatic colony counter. Negative and
positive strain-speciﬁc and S9-speciﬁc control substances (DMSO,
daunomycin, 2-aminoanthracene, 2-aminoﬂuorene) were assayed
in parallel. Control results were always within the historical range.2.4. Test strategy
Each HAA identiﬁed and quantiﬁed in TPM by the method
described above was tested in the Ames assay for mutagenicity
alone, in combination with TPM from the standard reference
cigarette 2R4F, and in combination with the other identiﬁed and
quantiﬁed HAAs.
Based on the dose/response data published in the literature for
the testing of HAAs in the Ames assay, dose ranges were expanded
far beyond the yields that could be expected to be found in TPM.
2.5. Statistics
Data are presented as arithmetic means and standard devia-
tions (SD) or standard errors of the means (SE). The normal
mutagenic response for TPM is characterized by a linear increase in
the number of revertants as the amount of TPM is increased. At
higher doses the linearity vanishes (Bernstein et al., 1982). The
mutagenic response reported here was calculated as the slope
(revertants per plate/mg or ng TPM) of the linear portion of the
dose-response curve ﬁtted with Poisson-weights to the data, often
referred in the literature as speciﬁc mutagenicity. Likewise, the
HAAs, at lower doses, showed a linear mutagenic response as a
function of the dose. For these, curve ﬁts were done in the same
way. The spontaneous revertants were subtracted in all calcu-
lations.
For the assessmentof additivity, it was assumed, that the addition
of a single dose of TPM should shift the linear dose/response curve of
the HAA upward by an amount equal to the response of the TPM
alone. Likewise, for the combination of all HAAs the sum of all single
responses at a given dose was assumed as the expected response
under the assumption of additivity. This simpliﬁed approach does
not account for, e.g., slight deviations from linearity already starting
at low doses or that the ﬁt of the linear dose/response line does not
start exactly at the origin (x = 0, y = 0). However, this approach is
considered to be adequate to conclude, if there are biologically
relevant deviations from additivity or not.
3. Results
3.1. Chemical analyses
Eight of the 9 HAAs reported to be cigarette smoke constituents
could be detected and quantiﬁed. Trp-P-1 could not be detected.
MeAaC, PhIP, IQ, and MeIQ could be derivatized twice (PCI mode).
AaC, Glu-P-1, Glu-P-2, and Trp-P-2 could only be derivatized with
PFAA (NCI mode).
The yields per cigarette varied among the 8 HAAs considerably.
From the HAA with the lowest yield (Glu-P-1) to the highest yield
(AaC) there was a factor of 660. With the exception of MelQ, the
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cigarette 2R4F. The associated relative standard errors were around
5% (see Table 1). The optimized method showed high selectivity
and less interferences of co-eluting compounds, good signal-to-
noise ratios (resulting in low limits of quantiﬁcation), a wide linear
range of quantitation, and good accuracy and reproducibility.Fig. 1. Mutagenic response (M, SE) in Salmonella typhimurium tester strain TA98 + S9 meta
(dashed lines; two experiments) and together with a constant dose of 100 mg TPM (so3.2. Biological assessments
3.2.1. Mutagenicity of single HAAs, contribution to and interference
with mutagenicity of TPM
The 8 HAAs which could be quantiﬁed in 2R4F cigarette smoke
were tested as pure substances. In concentrations above those
present in 2R4F cigarette smoke, all 8 HAAs showed clearbolic activation towards HAAs present in cigarette smoke, dosed as pure substances
lid lines). Standard errors are too small to show up in the graphs.
Table 2
Calculated contributions of the HAAs to the in vitro mutagenicity of cigarette smoke TPM in Salmonella typhimurium tester strain TA98 + S9 metabolic activation, based on their
amount in TPM and their speciﬁc mutagenicity as neat substances.
Substance Speciﬁc mutagenicity (revertants/ng) HAA-yield (ng/cig.) Total mutagenicity (revertants/cig.) Contribution to TPM mutagenicity (%)
Mean SD
2R4F-TPM 0.0037 – 43976 100
AaC 0.248 0.002 28.4 7.05 0.016
MeAaC 0.399 0.058 7.57 3.0 0.007
PhIP 1.41 0.20 0.086 0.1 0.000
Glu-P-2 25.0 9.6 0.211 5.3 0.012
IQ 36.8 4.2 0.324 11.9 0.027
Glu-P-1 45.6 5.2 0.0430 2.0 0.004
Trp-P-2 46.7 0.11 4.40 205.3 0.467
MeIQ 823.0 60.0 0.338 278.2 0.633
Sum 979 – – – 1.17
Fig. 2. (A) Mutagenicity of a mix of the 8 quantiﬁed HAAs in the ratio they occur in TPM. Dosing was performed as multiples of the concentration occurring in 1 mg TPM (TPM
equivalents); (B) Mutagenicity of TPM of the reference cigarette 2R4F, mixes of the 8 HAAs 10 times and 100 times higher than in the respective TPM dose, alone (MIX10 and
MIX100) and in combination with TPM of the reference cigarette 2R4F (MIX10/2R4F and MIX100/2R4F).
Remarks: standard error in most cases too small to show up in the graphs.
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single HAAs differed by 3 orders of magnitude (see Fig. 1).
TPM also showed a clear mutagenic response at 100 mg TPM/
plate with nearly 400 revertants/plate, which was still within the
linear dose-response range. Choosing this as a reference dose, the
HAAs generally showed a linear response up to doses that were
several 1000 times higher than the response from 100 mg TPM.
Only Trp-P-2, and possibly Glu-P-2, showed a decline in the
steepness of the dose-response curve at a dose 300 times higher
than that present in 100 mg TPM (see Fig. 1).Applying more rigid demands on the linearity and thus
excluding doses that showed statistically signiﬁcant (p < 0.05)
deviations from linearity, the speciﬁc mutagenicity (revertants/ng
HAA) of AaC showed the shallowest response slope with an
activity about 50 times higher than that of TPM. MelQ showed the
highest response being 200,000 times more active than TPM
(Table 2). Calculations, based on the activity of individual HAAs as
pure substances and their yields in TPM, revealed that the total
contribution of HAAs was about 1% to the total mutagenicity of
TPM.
Table 3
Yields of HAAs in smoke of different cigarettes as reported in the literature and reported in this study.
Yields of heterocyclic aromatic amines in cigarette smoke (ng/cig.) Reference
AaC MeAaC Trp-P-1 Trp-P-2 Glu-P-1 Glu-P-2 PhIP IQ MeIQ
25–258 9–37 Yoshida and Matsumoto (1980)
80 6 Matsumoto et al. (1981)
0.26 Yamashita et al. (1986)
0.66 0.63 Kanai et al. (1990)
0.25 0.59 Manabe and Wada (1990)
42 2.5 0.2–0.3 0.5–0.7 Manabe et al. (1990)
11–23 Manabe et al. (1991)
Wakabayashi et al. (1995)
nd-2 0.3–0.7 nd nd 0.3–0.5 0.3–0.8 Kataoka et al. (1998)
nd nd nd 0.5–4.7 0.3–2.6 Sasaki et al. (2001a,b); Sasaki et al. (2001a,b)
30–60 5–10 Smith et al. (2004)
49–95 2–11 0.3–1.9 1.2–9.2 Zhang et al. (2011)
28 8 nd 4 0.04 0.2 0.09 0.3 0.3 This study
nd = not detected.
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with mutagenicity of TPM
When applying mixtures of all 8 HAAs in the same concentra-
tion ratio as measured in TPM, and in doses up to approximately
1000 times the amount found in 1 mg TPM, the mutagenic
responses were not different from background levels as one would
expect under the assumption of simple additivity. At higher doses
the responses were linear, but weak, and distinctly lower than
expected. At a dose of 10,000 times the amount found in 1 mg TPM,
a factor of approximately 5 between expected and measured
responses could be calculated (Fig. 2A).
When TPM at doses of up to 160 mg/plate was fortiﬁed with
mixes of the 8 HAAs at 10 and 100 times the amount already




Analytes occurring only in ng/g amounts in a matrix constitute a
special challenge for the analytical chemist. This holds especially
true for cigarette smoke which contains approximately 8700 iden-
tiﬁed constituents (Rodgman and Perfetti, 2013). For the analysis of
HAAs in cigarette smoke reported in the current study, the method
reported by Sasaki et al. (2001b) was further optimized by use of
triple quadrupole technology in both PCI and NCI modes instead of
using single quadrupole technology only in the NCI mode. This
resulted in a higher selectivity, lower limits of quantiﬁcation, and
better accuracy and reproducibility.
With these modiﬁcations, it was possible to measure the yields
of 8 of the 9 HAAs reported in cigarette smoke TPM (see Table 3).
The presence of Trp-P-1 could not be conﬁrmed. With one
exception, the amounts of Trp-P-1 in TPM reported in the literature
are below 1 ng/cigarette. There are no analytical methods in the
available literature that report on the measurement of 8 HAAs in
TPM in one run. Comparing the reported yields of HAAs in TPM of
cigarettes from different markets which have been obtained using
different analytical methodologies, the reported data in the
present study are well within the reported yield ranges providing
conﬁdence that the reported results are not biased, e.g., by
interference from other smoke constituents or other artefacts (see
Table 3).
4.2. Biological assessments
S. typhimurium mutagenicity (Ames assay) data reported in the
literature show a rather high variation from laboratory tolaboratory. From the data for the mutagenic response of HAAs
in S. typhimurium tester strain TA98 with metabolic activation
reported in different laboratories and summarized by the
International Agency for Research on Cancer (IARC, 2015), the
following lowest dose (ng/ml) to exhibit a mutagenic effect can be
calculated: PhIP 54.8  86.2, IQ 50.3  100, and MeIQ 2.6  5.7
(means and standard deviations). The high variation is most
probably due to differences in the competence of the metabolic
activation systems, as the HAAs exert their mutagenic activity only
after metabolic activation. It has been shown, that different
S9 fractions for metabolic activation alter the number of revertants
in the Ames assay by more than a factor of 10 (Kato, 1986).
However, this high variation generally does not constitute a major
drawback, when comparing mutagenic potencies of different test
substances obtained under identical conditions. Similar to previ-
ous studies, S. typhimurium tester strain TA98 with metabolic
activation was used to determine the mutagenic activity of HAAs
since it has been shown that this strain is the most responsive
strain to the mutagenic activities of HAAs (Felton et al., 1995;
Schwab et al., 2000) and cigarette smoke TPM (Roemer et al., 2012).
Together with a low intra-study variability, this assay variant
qualiﬁes best for the detection of possible differences in
mutagenicity between different test substances in the context of
HAAs and TPM.
The bacterial mutagenicity results for the single HAAs are well
within the reported ranges in literature. Considering the broad
literature ranges, as pointed out above, this was expected. More
importantly, however, the potencies of the single HAAs relative to
each other obtained in this study ﬁt to those reported in the
literature (Shishu et al., 2003). Mixes of the 8 HAAs gave rise to
responses that were distinctly below that expected under the
assumption of additivity for the single HAAs. Considering the
rather high doses applied, there are several probable explanations
for this sub-additive effect: the metabolic activation system was
overwhelmed, the metabolic products have some protecting
properties, or the high amount of HAAs with rather low activity
have gained a competitive advantage over the more active ones at
the side of action within the cells. This phenomenon is deemed
only of theoretical interest, because of the unrealistic high doses of
HAAs applied. The same holds true for the sub-additive effects
when combining TPM and HAAs.
In contrast to the results reported here, a profound sub-additive
effect resulting from the combination of increasing amounts of
TPM added to a ﬁxed dose of a single HAA has been reported using
the same test system (TA98 + S9) and 6 HAAs investigated here (Lee
et al., 1994). The response of nearly all HAAs could be reduced up to
approximately 50%. For three of the HAAs tested here (MelQ, Glu-
P-1, Trp-P-2), the observed strong reduction reported by Lee et al.
46 E. Roemer et al. / Toxicology Letters 243 (2016) 40–47(1994) could not be reproduced. For the other three HAAs (IQ, Glu-
P-2, Trp-P-1) the applied doses by Lee et al. were distinctly higher
than the high doses applied in the current study, and thus, do not
allow a comparison of the data.
In conclusion, toxicity data on HAAs provided in the literature
and the results on bacterial mutagenicity obtained in the present
study under test conditions described suggest that the minute
amounts of HAAs in cigarette smoke TPM play a negligible role in
the in vitro mutagenic activity of cigarette smoke.
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